@ facial , high risk ( diameter at least @cm , H-zone location or aggressive histological subtype ) primary BCCs ( pBCCs ) and @ facial recurrent BCCs ( rBCCs ) were randomly allocated to treatment with either SE or MMS between @th October @ and @th February @ .